X
07Jan

DEAL WATCH: End-of-Year Biosimilar Agreements

Goodwin | | Return|
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/deal-watch-end-of-year-biosimilar-10061/

Related

DOL Announces Final Rule Increasing Minimum Salary Threshold for FLSA White Collar Exemptions

In a much-anticipated move, the United States Department of Labor ("DOL") announced yesterday the fi...

Read More >

Annual EEO Public File Report Deadline for Stations in Arkansas, Kansas, Louisiana, Mississippi, Nebraska, New Jersey, New York, and Oklahoma

February 1 is the deadline for broadcast stations licensed to communities in Arkansas, Kansas, Louis...

Read More >

Calculated to Be Understood by the Average Plan Participant – How Does the DOL Score?

ERISA requires Summary Plan Descriptions and other disclosures to be "written in a manner calculated...

Read More >

Fifth Circuit Deals a Blow to EEOC’s Criminal Record Guidance

On August 6, 2019, in Texas v. EEOC, the U.S. Court of Appeals for the Fifth Circuit dealt the EEOC ...

Read More >

SEC Amends Financial Statement Requirements for Business Acquisitions and Dispositions

In May 2020, the US Securities and Exchange Commission announced amendments to the rule and forms re...

Read More >

Sustainable Development and Land Use Update - September 2020 #1

Bid to allow duplexes on most California lots fails after Assembly approval comes too late...Califor...

Read More >